03/25/2026
Excited to see Sparrow at the center of an important milestone in cardiovascular disease detection. Sunnybrook Health Sciences Center and KMH Cardiology Centres Inc. have launched the first clinical trial in Canada evaluating Sparrow’s Stethophone for the early detection of aortic stenosis, a common and often underdiagnosed heart valve disease.
Using heart sounds captured through a smartphone, Stethophone supports earlier recognition of cardiac signals that may indicate aortic stenosis, helping clinicians identify patients who may benefit from further diagnostic evaluation. The platform is designed to extend disease detection capability into routine patient encounters, generating structured signals that can guide referral and testing decisions.
As evidence develops, technologies like Stethophone may help health systems address an important upstream detection gap. Large numbers of patients pass through clinical encounters each year without producing a structured cardiovascular disease signal that triggers evaluation.
Scalable tools that can capture these signals during routine care could make earlier identification of valvular heart disease more practical within existing care pathways. With an aging population and rising prevalence of aortic stenosis, expanding disease detection upstream has the potential to influence how and when patients are identified, evaluated, and ultimately treated.
🔗 Read more (link in stories)